This past week, the FDA approved the first generic version of pioglitazone (Actos) for the treatment of T2DM.
As I had anticipated, the FDA News Release mentioned the concern that the current version of pioglitazone (Actos brand) has been associated with some nasty side effects, including an increased risk of heart problems, and risk of bladder cancer: “The drug has a Boxed Warning to emphasize that pioglitazone may cause or worsen heart failure, particularly in certain patient...
Good news for those who have been using Maxalt and Maxalt-MLT to treat their Migraines. The patents on both Maxalt products have expired,... Read more »
Mylan Pharmaceuticals has received tentative approval from the FDA to sell a generic version of Depakote ER, owned by Abbott Laboratories.... Read more »
One of our forum members asked today if Stadol Masal Spray has been discontinued because her pharmacist had notified her that it was and he... Read more »
For all of you who are using Topamax for Migraine and headache prevention, there's good news. Generic topiramate has been approved by the... Read more »
Two weeks ago I told you that the FDA approved a generic version of Lyrica® (pregabalin) made by Lupin Limited but I wasn't able to find... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2013 Remedy Health Media, LLC. All Rights Reserved.
10 Things Not to Say to Someone With Depression 
6 Behavior Changes During Depression 
Getting to Know Your 5 Essential Brain Chemicals 
7 Ways to Make the Concrete Jungle Greener 
